Lawrence Poulakos

Effects of accelerated fractionation on radiation injury of the small intestine: A new rat model

The present study assessed the influence of shortening the overall treatment time (accelerated fractionation) on radiation injury of the small intestine. A rat model which allowed repeated irradiation of a localized segment of small intestine was developed. Young adult male Sprague-Dawley rats were orchiectomized, and a loop of the distal ileum was transposed to the left part of the scrotum. The intestinal segment was irradiated with a total dose of 56 Gy, given in 20 fractions, the total treatment time being either 26, 12, or 7 days (i.e. 1, 2, or 3 fractions per day). Radiation injury was assessed by histopathologic examination at 6 hr and at 2 weeks after the last irradiation. The surgical procedure was without complications. Shortening the overall treatment time by giving more than one radiation dose per day resulted in markedly increased injury both at 6 hr and at 2 weeks. It is concluded that accelerated fractionation results in increased radiation injury of the intestine when compared with standard fractionation. Because there may be a relationship between early and late effects in the intestine, our results also indicate that increased late radiation enteropathy may result from accelerated fractionation.

INTESTINAL COMPLICATIONS FOLLOWING ACCELERATED FRACTIONATED X-IRRADIATION An experimental study in the rat

Due to paucity of suitable animal models, it has been difficult to study the development of long-term intestinal complications following fractionated irradiation. We recently developed a model which allows multiple radiation exposures of a short segment of rat ileum without the need for repeated surgery. In the present series, this model was used to study the influence of shortening the total treatment time (accelerated fractionation) on development of radiation enteropathy. Male rats were orchiectomized and a short segment of distal ileum was transposed to the scrotum. Starting 3 weeks after surgery, the scrotum containing the intestinal segment was x-irradiated with 20 fractions of 2.8 Gy (total dose 56 Gy). Two fractionation schedules were compared: One fraction per day (total treatment time 26 days) and 3 fractions per day (total treatment time 7 days). Actuarial survival curves were obtained, and the degree of radiation injury was assessed 2, 8, and 26 weeks after the last radiation exposure using a semiquantitative histopathologic scoring system. There was no mortality from acute radiation injury in either treatment group. All animals of the 1-fraction/day group survived the observation period (26 weeks). In the 3-fraction/day group, there was significant mortality due to intestinal obstruction, and cumulative mortality at 26 weeks was 100%. Radiation injury, as assessed by the histopathologic scoring system, was also more pronounced in this group than in the 1-fraction/day group. We conclude that shortening the total treatment time significantly increases the severity of late intestinal complications. Our data are suggestive of an association between acute mucosal damage and chronic radiation injury of the small intestine.

The prevalence and severity of late effects in normal rat duodenum following intraoperative irradiation.

In humans, a portion of the duodenum is often at risk for radiation-induced complications following intraoperative radiation therapy for pancreatic carcinoma. To determine experimentally the prevalence and severity of late effects in the normal mammalian duodenum, 190 rats received single doses of 0, 15, 20, 25, 30, or 40 Gy orthovoltage X rays to temporarily exteriorized 3 cm circumferential segments of duodenum. The animals were killed 2, 6, 8, or 10 months later. Actuarial survival, change in body weight, and a radiation injury score based on eight histopathologic alterations were used as endpoints. Epithelial atypia, intestinal wall fibrosis, serosal thickening, and vascular sclerosis were the dominant histopathologic alterations at all dose levels throughout the 10-month observation period. The prevalence and severity of histologic radiation injury showed sigmoidal dose-response relationships with the plateaus starting at 20 Gy. Doses of 20 Gy or greater also resulted in a substantial loss of body weight and a high level of early deaths (20-80 days). All endpoints indicate that intraoperative doses of 20 Gy or greater are associated with unacceptable risks of late and irreversible complications.

The Kinetics of Cellular Recovery in Locally X-Irradiated Rat Ileum

treated and control animals were given tritiated thymidine ip and killed one hour later. The irradiated or sham-irradiated segment and segments of shielded intestine 5 cm and 10 cm distal to the irradiated or sham-irradiated segments were removed and appropriately processed for histologic and autoradiographic studies. At each time sampled, the number of total cells per crypt section in both the irradiated segment and the shielded segment 5 cm distally was greater than in the respective control segments. The differences between treated and control values decreased with time after irradiation. The percent labeled cells per crypt section for samples from the irradiated area and from the segment located 5 cm distally were not different from controls. The total cells, labeled cells, and percent labeled cells per crypt section in the segment located 10 cm distally were not different from the respective control values. The results obtained indicate that local irradiation of the intestine does not change the relative size of the proliferative compartment. This is in contrast to the situation which exists after whole-body exposure to 1000 R in which the entire crypt becomes proliferative. The mucosal cell proliferation rate is slightly increased in a shielded ileal segment 5 cm from the site of local irradiation, suggesting that there is an attempt by adjacent unirradiated tissue to compensate for the temporary loss of functional crypts. The compensatory increase in cellularity in both the irradiated and shielded intestine, followed by a decrease toward control values with time after irradiation and increased distance from the irradiation site, suggests a local, temporary influence associated with

Effects of exocrine pancreatic secretions on hyperthermic injury of rat small intestine

The influence of the exocrine pancreatic secretions on development of small intestinal injury following localized hyperthermia was studied. In male Holtzman rats the excretory pancreatic ducts were occluded with metal hemostatic clips. An intraperitoneal injection of [3H]thymidine was given 3 weeks later. Three or 48 h after the injection a 10 cm segment of small intestine was exteriorized through a midline abdominal incision and heated at 38.0 degrees C, 42.5 degrees C, or 43.5 degrees C for 45 min. Intestinal damage was assessed 24 h after hyperthermia. The following four endpoints were used: histopathological injury score, the number of villi per intestinal circumference, the number of labelled epithelial cells in fixed areas of autoradiographic specimens, and incorporation of [3H]thymidine as determined by liquid scintillation counting. The correlation of results among the four methods of assessment was highly significant. The autoradiography data showed better correlation with both morphological parameters than the results of liquid scintillation counting. There was significantly less damage in heated segments from pancreatic duct-occluded animals than in segments from sham-operated controls. When hyperthermic injury was assessed morphologically the protection conferred by pancreatic duct occlusion was equivalent to lowering the temperature of heating by 1 degree C. It is concluded that morphological criteria may be superior to endpoints based on [3H]thymidine incorporation for assessment of hyperthermic injury in rat small intestine. Reducing the intraluminal pancreatic secretions appears to confer significant protection from small bowel injury after localized hyperthermia.

Research Relating to Potential Applications of Pentoxifylline in Radiation Oncology

AbstractA series of experiments were performed over the last three years to test the usefullness of pentoxifylline in radiation oncology. In the first study, mouse feet were irradiated with doses of 4